Banana Broth May Simplify C. difficile Testing

The use of C diff Banana Broth may improve surveillance testing for Clostridioides difficile infection and optimize ...

JUNE 18, 2024

Microbiota-Based Therapy for the Prevention of Recurrent Clostridioides difficile Infection:
A Primer on REBYOTA^®
(fecal microbiota, live-jslm)

This Special Report outlines the challenges of treating Clostridioides difficile infection (CDI) and preventing ...

AUGUST 29, 2023

Impact of Live Biotherapeutic Products on C. difficile Recurrence

It is estimated that 500,000 people in the United States test positive for Clostridioides difficile infection (CDI) ...

NOVEMBER 17, 2022

VRBPAC Recommends Ferring’s Biotherapeutic to Reduce Recurrent CDI

The FDA Advisory Committee, VRBPAC issued a positive vote recommending Ferring’s biotherapeutic to reduce ...

SEPTEMBER 23, 2022

Limited Access to C. diff Drugs Through Medicare

While drugs recommended for the treatment of CDI are commonly included on the formularies for most people who are ...

AUGUST 19, 2022

Restoring the Full Diversity of the Gut Microbiome: Can It Break the Cycle of Recurrent C. Difficile Infection?

This Special Report provides a general overview of the role of the gut microbiome, the consequences of its ...

MAY 2, 2022

The Resurgence of the Tetracyclines

This monograph describes the pharmacokinetics and pharmacodynamics of tetracyclines and outlines the unique ...

DECEMBER 21, 2021

FDA Fast-Tracks FMT Product for C. difficile

The FDA awarded a fast track designation for CP101, an encapsulated, oral fecal microbiota transplant product by ...

APRIL 2, 2018

New C. difficile Guidelines Recommend New Treatment, Testing Protocols

CDI affects nearly 500,000 Americans every year, resulting in 15,000 to 30,000 deaths and costing more than $4.8 ...

FEBRUARY 15, 2018

New GenePOC Test Rapidly Detects C. diff

The GenePOC CDiff assay is a qualitative, in vitro diagnostic test to detect the toxin B gene of toxigenic C. ...

NOVEMBER 30, 2017